University of Chicago: Neoplasms trials
The registry lists 18 Neoplasms studies with University of Chicago as lead sponsor. 3 are open to participants now and 2 have results posted.
Early Phase 1 1Phase 1 12Phase 2 3No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Lactulose to Improve Gut Health in Cancer Patients Receiving ImmunotherapyRecruitingNCT07354100Phase 1/2
- Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI CancersNot yet recruitingNCT07126561Phase 2
- Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene InteractionsRecruitingNCT05166694Not applicable
- Engaging and Activating Cancer Survivors in Genetic Services StudyCompletedNCT04455698Not applicableResults posted
- Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic MalignanciesCompletedNCT00943592Phase 1/2Results posted
- Novel Outreach Methods to Increase Enrollment to Early Phase Clinical TrialsActive, not recruitingNCT05886764Not applicable
- Obstruction of Malignancy: Percutaneous Renal vs Endoscopic StentWithdrawnNCT05640115Early Phase 1
- Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin LymphomaActive, not recruitingNCT05019976Not applicable
- A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative NeoplasmsWithdrawnNCT04955938Phase 1
- Phase I Study to Assess the Tolerability and Efficacy of Nivolumab in Patients With Hematologic MalignanciesTerminatedNCT02985554Phase 1
- Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid TumorsActive, not recruitingNCT02608385Phase 1
- Ilorasertib in Treating Patients With CDKN2A-deficient Advanced or Metastatic Solid Cancers That Cannot Be Removed by SurgeryCompletedNCT02540876Phase 1
- A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid TumorsCompletedNCT02145559Phase 1
- Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By SurgeryCompletedNCT01791088Phase 1
- Study of Rapamycin Plus Ketoconazole in Advanced CancersCompletedNCT00708591Phase 1
- Rapamycin in Advanced CancersCompletedNCT00707135Phase 1
- Drug Interaction Study of Sorafenib and Rapamycin in Advanced MalignanciesCompletedNCT00449280Phase 1
- O6-benzylguanine Followed by Surgery in Treating Patients With Solid Tumors That Can Be Removed During SurgeryCompletedNCT00003766Phase 1